Target intelligence / Profile preview

NFATC2IP antisense RNA 1 (NFATC2IP-AS1)

Target
NFATC2IP-AS1
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

NFATC2IP antisense RNA 1 (NFATC2IP-AS1) is a long non-coding RNA (lncRNA) gene located antisense to the NFATC2IP (Nuclear Factor of Activated T Cells 2 Interacting Protein) coding gene[1]. As a non-coding RNA, NFATC2IP-AS1 does not encode a protein and its primary molecular function is presumed to be the regulation of its sense partner (NFATC2IP) or other genomic loci via RNA-mediated mechanisms such as transcriptional interference, RNA-DNA, or RNA-protein interactions[1]. There is no evidence it serves as a direct therapeutic target, biomarker, or has established roles in disease pathogenesis. Its biological role remains largely uncharacterized, with potential involvement in the regulation of protein-coding gene expression. Key notes for structured data extraction and curation: - "NFATC2IP antisense RNA 1" is not a receptor, enzyme, transporter, or canonical therapeutic target; it is a long non-coding RNA[1]. - No reported interacting drugs or mechanisms of drug action, nor is it recognized as a disease biomarker in currently available literature[1]. - While the NFATC2IP protein-coding gene has biological relevance in genome integrity and SUMOylation responses[2][6], these functions do not apply to the non-coding antisense transcript (NFATC2IP-AS1). If you intended the *protein-coding* NFATC2IP, distinct from the antisense RNA, please clarify, as this would require a different annotation (molecular class: protein, biological function: DNA repair, etc.)[2][4][6].

Other names
NFATC2IPAS1lncRNA NFATC2IP-AS1
02

Biological functions

Gene regulation (possible antisense regulation of NFATC2IP)non-coding transcript
03

Disease associations

Other (no established direct roles; possible indirect involvement via regulation of NFATC2IP protein-coding gene)

Beyond the preview

Go deeper on NFATC2IP antisense RNA 1 (NFATC2IP-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFATC2IP antisense RNA 1 (NFATC2IP-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call